Viral Polymerase Mechanism Overview

Principles

Definition

Viral polymerase mechanism is a fundamental concept and active research area in molecular virology that investigates the detailed biochemical and structural processes governing the synthesis of viral nucleic acids by viral polymerases. This field seeks to understand the molecular steps of viral genome replication and transcription, including enzyme-substrate interactions, catalysis, processivity, and fidelity, providing essential knowledge for understanding viral life cycles, pathogenesis, and identifying targets for antiviral therapies.

Ontological type

Catalytic Cycle

Antiviral Targeting

Structural Domains

Key developments

Key Figures

Polymerase Regulation and Initiation era

Joseph Sodroski[1], associated with Harvard University[2] and La Roche College[3], contributed to the Polymerase Regulation and Initiation era (1970-1988). His key contribution in this era was demonstrating trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells, as described in the 1984 paper <i>Trans</i>-Acting Transcriptional Activation of the Long Terminal Repeat of Human T Lymphotropic Viruses in Infected Cells[4], which linked promoter-dependent transcription to polymerase regulation and highlighted initiation as a regulatory-control point. Moreover, Sodroski's work at Harvard University[2] and La Roche College[3] helped establish the value of defined in vitro transcription systems and promoter element dissection as tools to interrogate initiation and translation coupling in viral polymerase regulation. Thus, Joseph Sodroski[1] helped lay foundational concepts and enduring tools for probing how initiation and translation control polymerase function in viral systems during this era.

Catalysis and Fidelity Unification era

Raffaele De Francesco [1] was active at The University of Texas Southwestern Medical Center [3] and United States Military Academy [4] during this era. His 1996 paper Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus [7] identified and characterized the viral RNA-dependent RNA polymerase, revealing active-site geometry and catalytic properties that framed the understanding of replication fidelity and antiviral targeting in catalysis and fidelity unification. Douglas D. Richman [2] was affiliated with Harvard University [5] and University of California, San Francisco [6] during this era. His 1990 paper Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication [8] demonstrated a multienzyme approach that models retroviral replication and enables probing of polymerase catalysis and fidelity, providing a methodological framework that underpins the era's mechanistic insights.

Structural Context and Inhibition era

In this era, representative work by Gao and colleagues advanced the structural understanding of coronavirus RdRp and its interaction with cofactors, providing a template for mechanism-guided inhibition. Stuart Le Grice's HIV-1 reverse transcriptase studies clarified active-site geometry and detailed how nucleotide-analogue engagement leads to stalled or delayed chain termination in retroviral polymerases. Lei Jiang and colleagues contributed cryo-EM and crystallographic insights into viral polymerase assemblies, including coronavirus RdRp complexes, revealing active-site engagement and conformational changes that underlie remdesivir-like inhibition. Feng Gao's structural investigations across RNA viruses highlighted how replication organelles and host cofactors modulate polymerase activity and influence drug accessibility, informing resistance-prediction and inhibitor design.